About APCO

The Asia Pacific Consortium on Osteoporosis (APCO) comprises Osteoporosis experts from several countries in Asia Pacific, charged with developing tangible solutions to the substantive challenges involving osteoporosis management and fracture prevention in this most populated and fastest growing region of the world.

Representing multiple medical and surgical specialties, the Consortium has developed a pan-Asia Pacific “Framework” for the introduction and implementation of minimum clinical standards for the screening, diagnosis and management of osteoporosis targeting a broad range of high-risk groups.

APCO became a free standing legal entity in October 2021 and we are registered as Asia Pacific Consortium on Osteoporosis HK Limited.

APCO strives to ensure equitable geographic representation of APCO members throughout Asia Pacific, to accommodate the wide variation in national population numbers in the region.

Osteoporosis in APAC

  • Osteoporosis and its dreaded complication of fragility fractures, compound the burden of Asia Pacific’s rapidly ageing societies.1
  • More than 1.1 million hip fractures were estimated to have occurred in China, Chinese Taipei, Hong Kong SAR, India, Japan, Malaysia, Singapore, South Korea and Thailand in 2018 incurring an estimated direct cost of USD 7.5 billion.2
  • By 2050, the number of hip fractures are projected to increase by 2.3-fold, to more than 2.5 million cases each year, resulting in staggering projected costs of almost USD 13 billion.2


To engage with relevant stakeholders, including healthcare providers, policy makers and the public, to help develop and implement country and region-specific programs for the prevention and treatment of osteoporosis and its complication of fragility fractures, in Asia Pacific.


To move towards reducing the burden of osteoporosis and fragility fractures in the Asia Pacific region
This will be achieved by:
  • Securing stakeholder acceptance of osteoporosis as a key public health priority
  • Creating solutions to minimise the burden of osteoporosis and reduce fragility fractures
  • Enabling healthier ageing through fewer fractures

Strategic Plan

The APCO Strategic Plan ‘At A Glance’ 2019 – 2021 summarises the organisation’s mission, vision and strategic priorities.

See below for an overview of the goals, initiatives and timeframe for APCO to achieve each of its strategic priorities. One of APCO’s aspirations is to be a catalyst and enabler for individuals who are passionate about osteoporosis. Read the APCO Strategic Plan here.

Parties wishing to collaborate with APCO to achieve its vision of reducing the burden of osteoporosis and fragility fractures in the Asia Pacific region, should contact APCO Chairperson, Dr Manju Chandran (email: secretariat@apcobonehealth.org). A full version of the APCO Strategic Plan is available upon request.

APCO’s Strategic Plan 2019-2021 outlines the organisation’s priorities over the course of three years:
  • Year 1

    Focus on broadening the professional composition of APCO, maximising awareness of the consortium, and engaging healthcare professional organisations throughout APAC to contribute to development of the Framework.

  • Year 2

    Launch of the Framework and promotion of health professional education and policy and advocacy activities pertaining to the Framework.

  • Year 3

    Showcase APCO’s work, recognise progress achieved to date, and highlight future strategic plans for the consortium.

Disrupting the status quo in osteoporosis management in the Asia Pacific – The Asia Pacific Consortium on Osteoporosis (APCO) and The APCO Framework

The APCO expert video series captures the individual voices of four key APCO members. These members  represent the diverse make up of APCO – a unique organisation comprising 54 osteoporosis experts from 23 countries and regions in the Asia Pacific, whose collective ideology crosses political boundaries and barriers.

Each expert reflects on the osteoporosis landscape in their respective country, outlines various efforts underway to address the burden of osteoporosis, and explains how The APCO Framework can be implemented across the region to improve the screening, diagnosis, and management of osteoporosis.

In addition, the Chairperson of APCO, Professor Manju Chandran, reflects on the establishment of APCO and its altruistic intent. The CEO of the International Osteoporosis Foundation (IOF) and APCO Executive Committee Member, Dr Philippe Halbout, discusses the unique perspective the IOF brings to APCO.



Launched in Singapore on May 4, 2019, APCO currently comprises clinical expert representatives from the following countries and regions:
  • Australia
  • Bangladesh
  • Bhutan
  • Brunei
  • China
  • Chinese Taipei
  • Hong Kong SAR
  • India
  • Indonesia
  • Japan
  • Korea
  • Malaysia
  • Mongolia
  • Myanmar
  • Nepal
  • New Zealand
  • Pakistan
  • Philippines
  • Singapore
  • Sri Lanka
  • Switzerland
  • Thailand
  • Vietnam


APCO Executive Committee Chair

APCO Executive Committee Chair is the 2021 International Osteoporosis Foundation Olof Johnell Science Award Winner - Dr. Manju Chandran, Senior Consultant Endocrinologist and Director of the Osteoporosis and Bone Metabolism Unit, that she established at Singapore General Hospital in 2007.

Dr Chandran holds a Fellowship in Endocrinology and Metabolism from the University of California San Diego School of Medicine, USA. In addition to being the immediate Past Chair of the Chapter of Endocrinologists, College of Physicians, Academy of Medicine Singapore, she is also the Deputy Chair of the Asia Pacific and South Africa Regional Advisory Council of the International Osteoporosis Foundation (IOF) and the Vice Chair of the Asia Pacific Panel of the International Society of Clinical Densitometry (ISCD).

She was awarded the IOF Young Investigator Award in 2013, the IOF CNS (Committee of National Societies) Medal of Excellence in 2015 and the IOF Olof Johnell Science Award in 2021. Dr Chandran was appointed to the IOF Board in 2020.

Dr Manju Chandran
APCO Executive Committee members
(as of October 2021)
  • 1 Dr Philippe Halbout, International Osteoporosis Foundation, Nyon, Switzerland
  • 2 Dr Greg Lyubomirsky, Healthy Bones Australia, Sydney, Australia
  • 3 Professor Peter Ebeling, AO, Monash Health, Melbourne, Australia
  • 4 Professor John Eisman, AO, Emeritus Fellow, Osteoporosis and Translational Research Lab, Garvan Institute of Medical Research, Sydney, Australia
  • 5 Professor Tuan Nguyen, University of Technology Sydney, Sydney, Australia
  • 6 Dr Cae Tolman, Amgen, Industry Representative, Sydney, Australia (non-voting member)
  • 7 Dr Tiu Kwok Leung, Queen Elizabeth Hospital, Hong Kong, Hong Kong SAR
  • 8 Professor Sanjay K. Bhadada, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
  • 9 Adjunct Associate Professor Paul Mitchell, School of Medicine, University of Notre Dame Australia, Australia
  • 10 Dr Nigel Gilchrist, Canterbury District Health Board, Christchurch, New Zealand
  • 11 Dr Aysha Habib Khan, Aga Khan University, Karachi, Pakistan
  • 12 Dr Sarath Lekamwasam, University of Ruhuna, Matara, Sri Lanka
Other APCO members
(as of October 2021)
  • 1 Professor Minhaj Rahim Choudhury, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • 2 Associate Professor Md. Abu Shahin, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • 3 Dr Yung Chee Kwang, Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam
  • 4 Professor Weibo Xia, Peking Union Medical College Hospital, Beijing, China
  • 5 Dr Zhao Yanling, Beijing United Family Hospital, Beijing, China
  • 6 Professor Qun Cheng, Huadong Hospital affiliated to Fudan University, Shanghai, China
  • 7 Professor Derrick Chan, National Taiwan University Hospital, Taipei, Chinese Taipei
  • 8 Dr Edith Lau, Hong Kong Orthopaedic and Osteoporosis Center for Treatment and Research, Hong Kong, Hong Kong SAR
  • 9 Professor Ambrish Mithal, Max Healthcare - Saket, New Delhi, India
  • 10 Professor Liu Jianmin, Shanghai Ruijin Hospital, Shanghai, China
  • 11 Dr Tai-Pang Ip, Tung Wah Hospital, Hong Kong, Hong Kong SAR
  • 12 Dr Usha Sriram, Indian Society of Bone and Mineral Research (ISBMR), Chennai, India
  • 13 Dr Thomas Paul, Christian Medical College, Vellore, India
  • 14 Professor Manoj Chadha, Hinduja Hospital and Research Centre, Mumbai, India
  • 15 Dr Gunawan Tirtarahardja, Indonesian Osteoporosis Association, Jakarta, Indonesia
  • 16 Professor Akira Taguchi, Matsumoto Dental University, Nagano, Japan
  • 17 Professor Atsushi Suzuki, Fujita Health University, Toyoake, Japan
  • 18 Professor Hajime Orimo, Japanese Osteoporosis Foundation, Tokyo, Japan
  • 19 Dr Hew Fen Lee, Puchong Medical Specialist Centre and Subang Jaya Medical Centre, Malaysia
  • 20 Dato’ Dr Lee Joon Kiong, Beacon Hospital, Petaling Jaya, Malaysia
  • 21 Dr Tet Tun Chit, Yangon General Hospital, Yangon, Myanmar
  • 22 Professor Tint Swe Latt, Shwe Baho Hospital, Yangon, Myanmar
  • 23 Dr Dipendra Pandey, National Trauma Centre, Kathmandu, Nepal
  • 24 Professor Ian Reid, CNZM, University of Auckland, Auckland, New Zealand
  • 25 Dr Irewin Tabu, University of the Philippines - Philippine General Hospital, Manila, Philippines
  • 26 Professor Leilani Asis, University of the Philippines, Manila, Philippines
  • 27 Professor Yoon-Sok Chung, Ajou University School of Medicine, Suwon, Republic of Korea
  • 28 Dr Dong Ock Lee, National Cancer Center, Goyang, Republic of Korea
  • 29 Professor Kee Hyung Rhyu, Kyung Hee University, Seoul, Republic of Korea
  • 30 Dr Lau Tang Ching, National University Hospital, Singapore, Singapore
  • 31 Dr Tanawat Amphansap, Police General Hospital, Bangkok, Thailand
  • 32 Dr Thanut Valleenukul, MD, Bhumibol Adulyadej Hospital, Bangkok, Thailand
  • 33 Associate Professor Vu Thanh Thuy, Bach Mai Hospital, Hanoi, Vietnam
  • 34 Dr Lan Ho-Pham, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam
  • 35 Associate Professor Nicholas Pocock, St Vincent's Hospital, Sydney, Australia
  • 36 Dr Myadagmaa Jaalkhorol, Mongolian Naran Society for Osteoarthritis and Musculoskeletal Health, Ulaanbaatar, Mongolia
  • 37 Professor Moe Wint Aung, Yangon General Hospital affiliated to University of Medicine 1, Yangon, Myanmar
  • 38 Dr Kinzang Dorji, Eastern Regional Referral Hospital, Mongar, Bhutan
  • 39 Prof Jawl-Shan Hwang, Taiwanese Osteoporosis Association, Taipei, Chinese Taipei
  • 40 Dr Paulus Rahardjo, Indonesian Osteoporosis Society (PEROSI), Jakarta, Indonesia
  • 41 Associate Professor Julie Tan Li-Yu, University of Santo Tomas, Manila, Philippines
  1. The Economist Intelligence Unit, Ageing with strength: Addressing fragility fractures in Asia-Pacific. 2019.

  2. Ebeling, P., et al., Secondary prevention of fragility fractures in Asia Pacific: an educational initiative. Osteoporosis International, 2019.
Scroll to Top